Abstract
dc:descriptionTim-3, a member of the novel TIM (T cell immunoglobulin- and mucin-containing-domain) family of molecules, is the first molecule identified to be specifically expressed on CD4+ Th1 and not on Th2 cells. Tim-3 negatively regulates Th1 immunity and induces tolerance, but it's function has not been clarified in tumor immunity. To explore the effect of Tim pathway blockade on tumor growth using Tim-3-Ig fusion protein, two approaches were adopted. First, it was investigated whether Tim-3-Ig expression in lung carcinoma cells (3LL) affects tumor growth in mice. Second, it was investigated whether administration of purified Tim-3-Ig into mice influences tumor growth. Tumor growth of 3LL cells expressing Tim-3-Ig was suppressed as compared with control mouse groups. Further tumor growth in mice injected with purified Tim-3-Ig was inhibited as compared with control mouse groups injected with human Ig and PBS, respectively. Additionally, Mammal I revealed the importance of Tim-3 glycosylation for its binding activity to Tim-3 ligand using Tim-3-Ig expressed by mammalian cells and by Sf 9 cells. My results showed suppressive effect of Tim-3-Ig on tumor growth, implying significance of Tim-3-Tim-3 ligand pathway in tumor immunology.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- 허, 유미
- Contributors dc:contributor
-
- 박, 선
- 대학원 의학과
- 200424344
Subjects
dc:subject × 5Rights
- Language dc:language
- ko
Identifiers
dc:identifier.*- Identifier
-
http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000001872
000000001872 - OAI identifier oai:identifier
- oai:repository.ajou.ac.kr:201003/1622